Immediate Impact
2 by Nobel laureates 11 from Science/Nature 55 standout
Citing Papers
Towards targeting the breast cancer immune microenvironment
2024 Standout
Designing antibodies as therapeutics
2022 Standout
Works of Hans Kreipe being referenced
Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
2015
Oncogenic PIK3CA mutations in lobular breast cancer progression
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hans Kreipe | 4388 | 5531 | 3226 | 426 | 13.4k | |
| Ib Jarle Christensen | 5523 | 5378 | 3950 | 443 | 15.0k | |
| Suzanne Kamel‐Reid | 4264 | 4303 | 2904 | 285 | 11.9k | |
| Giancarlo Pruneri | 6282 | 4186 | 4875 | 352 | 12.1k | |
| Massimo Aglietta | 7007 | 3599 | 1870 | 394 | 14.2k | |
| Gilbert Lenoir | 5210 | 6307 | 1923 | 254 | 15.3k | |
| Paul Elson | 4643 | 4404 | 2563 | 333 | 13.1k | |
| Rajyalakshmi Luthra | 3572 | 4890 | 3735 | 304 | 13.4k | |
| Ingo G.H. Schmidt‐Wolf | 3785 | 3834 | 1489 | 245 | 10.2k | |
| Falko Fend | 4607 | 3020 | 1242 | 408 | 10.7k | |
| Ahmad Awada | 9304 | 5051 | 2904 | 538 | 15.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...